India to gift 2 mn doses of Covid-19 vaccine 'Covishield' to Bangladesh

Bangladesh's health minister Zahid Maleque speaking at a press conference earlier today in Dhaka said, "Indian government will send some Covid vaccines to Bangladesh as a gift"

vaccine
A worker unloads COVISHIELD vaccine consignment from Serum Institute of India as it arrives at the Cold storage facility at Civil Hospital, ahead of the rollout of the vaccination program, in Ahmedabad on Tuesday.
ANI Asia
2 min read Last Updated : Jan 19 2021 | 6:41 AM IST

Bangladesh will receive 2 million doses of COVID-19 vaccine 'Covishield' as a gift from India on January 20.

Citing the letter by the Indian High Commission written to the Bangladesh Ministry of Health and Family Welfare, Dhaka Tribune reported that a special flight from India carrying the Oxford-AstraZeneca vaccines, locally manufactured by Serum Institute of India, would land at Shahjalal International Airport on January 20.

The Health Services Division under the Ministry has issued a letter to the drug regulator the Directorate General of Drug Administration (DGDA) to take appropriate steps to administer the vaccine.

The vaccines will be received and stored at DGHS' facilities, such as the Expanded Program on Immunisation (EPI), Dhaka Tribune further said.

Meanwhile, Health Minister Zahid Maleque said that additional storage for the COVID-19 vaccines will be provided by the United Nations Children's Fund (UNICEF).

On January 8, Bangladesh had approved the procurement of 30 million doses of Covishield COVID-19 vaccine from India.

Bangladesh drug regulator Directorate General of DGDA had authorised Beximco Pharmaceuticals Limited to import and distribute the COVID-19 vaccine from India. In the initial six months of the first phase, Beximco will procure five million vaccine doses per month, reported Dhaka Tribune.

An agreement was signed in November between the Bangladesh government and Serum Institute of India through which Beximco Pharma will avail 30 million doses of the COVID-19 vaccine.

Last year during foreign secretary Harsh Vardhan Shringla's visit to Bangladesh, it was emphasised that Bangladesh will be a priority recipient for the COVID-19 vaccine developed in India.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus VaccineBangladesh

First Published: Jan 19 2021 | 6:34 AM IST

Next Story